Anna Brown

Wel­come to End­points News’ man­u­fac­tur­ing briefs, where we bring you es­sen­tial news on new builds, col­lab­o­ra­tions, re­calls and more. Na­tion­al Re­silience is … Sign up

No­vo Nordisk is buy­ing a vac­cine man­u­fac­tur­ing fac­to­ry from No­vavax for $200 mil­lion to ex­pand pro­duc­tion of its cur­rent and fu­ture mam­malian-based prod­ucts, a spokesper­son

Wel­come to End­points News’ man­u­fac­tur­ing briefs, where we bring you es­sen­tial news on new builds, col­lab­o­ra­tions, re­calls and more. The FDA has Sign up to

CD­MO and lab­o­ra­to­ry prod­uct de­vel­op­er Ag­i­lent Tech­nolo­gies un­veiled its topline plans to reshuf­fle its busi­ness mod­el, which will see the con­sol­i­da­tion of op­er­a­tions and build

Wel­come to End­points News’ man­u­fac­tur­ing briefs, where we bring you es­sen­tial news on new builds, col­lab­o­ra­tions, re­calls and more. Sam­sung Bi­o­log­ics has Sign up to

The Eu­ro­pean Com­mis­sion is ask­ing bio­phar­ma and man­u­fac­tur­ing com­pa­nies about their re­ac­tion to No­vo Hold­ings’ pro­posed ac­qui­si­tion of Catal­ent, ac­cord­ing to Reuters. While the EC